Location
New York, NY
Holdings as of
6/30/2026
Date filed
7/9/2026
Form type
13F-HR
Num holdings
91
Total value ($000)
$333,810
Net value change ($000)
+56,862 (20.5%)
New positions
6
Sold out positions
9
Turnover %
4.8%
Sector allocation + QoQ delta (equities-only)
Prev filing: 4/10/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
NBIS 13,453 169.4%
TSM 7,592 47.1%
ASML 5,637 39.5%
STM 5,237 144.2%
NOK 4,698 50.1%
SFTBY 4,562 259.4%
Ascendis Pharma AS 4,531 NEW
LYG 3,322 97.0%
CRZBY 3,145 127.7%
UBS GROUP AG 2,856 26.8%
Top Reduces (Value $000, Stocks/ETFs)
ASND -3,382 -100.0%
KB -1,746 -27.8%
PDD -1,650 -100.0%
MKKGY -1,304 -100.0%
GRFS -1,267 -100.0%
INFY -1,184 -100.0%
BABA -814 -22.5%
AU -661 -16.9%
AZN -641 -8.4%
TCEHY -598 -11.3%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type